Mitsubishi Tanabe confirms plasma products spin-out, logs lacklustre sales

Japan's Mitsubishi Tanabe Pharma (MTP) has confirmed that it will spin out and merge its blood plasma fractionation operations with those of the Japanese Red Cross Society later this year.